Issued Patents All Time
Showing 1–25 of 27 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 12291724 | Tumor-infiltrating lymphocytes for adoptive cell therapy | Amod A. Sarnaik, Shari Pilon-Thomas, Hao Liu | 2025-05-06 |
| 12186404 | Delta-opioid receptor targeted agent for molecular imaging and immunotherapy of cancer | David L. Morse | 2025-01-07 |
| 12060438 | Cyclic peptide compounds and methods of use thereof | Lori Hazlehurst | 2024-08-13 |
| 11518980 | Tumor-infiltrating lymphocytes for adoptive cell therapy | Amod A. Sarnaik, Shari Pilon-Thomas, Hao Liu | 2022-12-06 |
| 11414455 | Toll-like receptor 2 ligands and methods of making and using thereof | David L. Morse, Josef Vagner, Robert J. Gillies, Amanda Huynh, Michael Doligalski | 2022-08-16 |
| 11406723 | Radiotherapeutic and companion imaging agents to target MC1R | David L. Morse, Robert J. Gillies, Thaddeus WADAS, Hyun Joo Kil, Narges K. Tafreshi | 2022-08-09 |
| 11123435 | TLR9 targeted therapeutics | Alan F. List, Sheng Wei | 2021-09-21 |
| 11078235 | Cyclic peptide conjugates and methods of use | Lori Hazlehurst, Christoph Rader, Xiuling Li | 2021-08-03 |
| 10793595 | Toll-like receptor 2 ligands and methods of making and using thereof | David L. Morse, Josef Vagner, Robert J. Gillies, Amanda Huynh, Michael Doligalski | 2020-10-06 |
| 10556928 | Stabilized peptoid-peptide hybrids and uses thereof | Amod A. Sarnaik | 2020-02-11 |
| 10449227 | Conjugates for immunotherapy | David L. Morse, Shari Pilon-Thomas, Scott Antonia | 2019-10-22 |
| 10426843 | Delta-opioid receptor targeted agent for molecular imaging and immunotherapy of cancer | David L. Morse | 2019-10-01 |
| 10392353 | Processes for making substituted quinazoline compounds using hydrogen bonding catalysts | Cheol K. Chung, Guy R. Humphrey, Zhijian Liu, Yingju Xu, Younong Yu | 2019-08-27 |
| 10197575 | Stabilized peptoid-peptide hybrids and uses thereof | Amod A. Sarnaik | 2019-02-05 |
| 10131674 | Process for preparing Substituted Indole Compounds | Daniel A. DiRocco, Ian Davies, Feng Peng, Louis-Charles Campeau, Yingju Xu | 2018-11-20 |
| 10118942 | Toll-like receptor 2 ligands and methods of making and using thereof | David L. Morse, Josef Vagner, Robert J. Gillies, Amanda Huynh, Michael Doligalski | 2018-11-06 |
| 10059740 | Integrin interaction inhibitors for the treatment of cancer | Lori Hazlehurst, Priyesh Jain, William S. Dalton | 2018-08-28 |
| 10053466 | Process for preparing chiral dipeptidyl peptidase-IV inhibitors | John Y. L. Chung, Feng Peng, Yonggang Chen, Amude Mahmoud Kassim, Cheng-Yi Chen +7 more | 2018-08-21 |
| 10011635 | Cyclic peptide conjugates and methods of use | Lori Hazlehurst, Christoph Rader, Xiuling Li | 2018-07-03 |
| 9862725 | Process for preparing chiral dipeptidyl peptidase-IV inhibitors | John Y. L. Chung, Feng Peng, Yonggang Chen, Amude Mahmoud Kassim, Cheng-Yi Chen +7 more | 2018-01-09 |
| 9409927 | Super lewis acidic borate esters as 18F-labeled PET probes | Haibin Tian | 2016-08-09 |
| 8853149 | Integrin interaction inhibitors for the treatment of cancer | Lori Hazlehurst, Priyesh Jain, William S. Dalton | 2014-10-07 |
| 7345022 | Anti-fibril peptides | Robert P. Hammer, Yanwen Fu, Tod J. Miller | 2008-03-18 |
| 7262163 | Short amphipathic peptides with activity against bacteria and intracellular pathogens | Thomas Scott Yokum, Frederick M. Enright, Philip H. Elzer, Robert P. Hammer | 2007-08-28 |
| 6566334 | Short amphipathic peptides with activity against bacteria and intracellular pathogens | Thomas Scott Yokum, Frederick M. Enright, Philip H. Elzer, Robert P. Hammer | 2003-05-20 |